3 results
Approved WMOCompleted
• To estimate the difference in the efficacy and safety of RAD001 10 mg p.o. daily dose in combination with bevacizumab 10 mg/kg administered intravenously every two weeks for first-line treatment of patients with metastatic carcinoma of the kidney…
Approved WMOCompleted
To evaluate the performance of MCS in cleansing a poorly prepared colon.
Approved WMOCompleted
This study aims to assess the safety and user acceptance (comfort and satisfaction with pumping program) of a modified Symphony program card, the INITIATE 2.0.